{"transactions":[{"id":679819,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-08-20T21:25:38.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":2293,"price":3.381,"value":7752.633,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":1056594,"source":{"system":"sec-edgar","filing":"0001140361-26-033913","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126033913/form4.xml","form_type":"4"}},{"id":685334,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-08-17T21:52:21.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":2837,"price":3.381,"value":9591.897,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":1058887,"source":{"system":"sec-edgar","filing":"0001140361-26-033417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126033417/form4.xml","form_type":"4"}},{"id":763506,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-26T23:47:15.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":76490,"price":1.691,"value":129344.59,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option represents a right to purchase a total of 76,490 shares of the Issuer's Common Stock, one-third of which became fully vested and exercisable on April 12, 2018, with the remaining two-thirds vesting in equal quarterly installments over the following two years."}],"balance_after":0,"derivative":{"exercise_price":1.691,"expiration_date":"2027-04-12","underlying":"Common Stock","underlying_shares":76490},"source":{"system":"sec-edgar","filing":"0001140361-26-022894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126022894/form4.xml","form_type":"4"}},{"id":763505,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-26T23:47:15.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":55684,"price":3.086,"value":171840.824,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold by the Reporting Person in order to pay the exercise price of a Stock Option and to cover certain taxes in connection with the exercise of the Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.08 to $3.105. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units that convert to common stock on a one-for-one basis."}],"balance_after":1061724,"source":{"system":"sec-edgar","filing":"0001140361-26-022894","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126022894/form4.xml","form_type":"4"}},{"id":763504,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-26T23:47:15.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":76490,"price":1.691,"value":129344.59,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units that convert to common stock on a one-for-one basis."},{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares received upon exercise of a Stock Option in advance of the expiration of such Stock Option."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units that convert to common stock on a one-for-one basis."}],"balance_after":1117408,"source":{"system":"sec-edgar","filing":"0001140361-26-022894","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126022894/form4.xml","form_type":"4"}},{"id":767708,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-21T20:06:07.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":2409,"price":3.014,"value":7260.726,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":1040918,"source":{"system":"sec-edgar","filing":"0001140361-26-022447","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126022447/form4.xml","form_type":"4"}},{"id":778848,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-14T20:19:30.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":2728,"price":3.606,"value":9837.168,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":1043327,"source":{"system":"sec-edgar","filing":"0001140361-26-021315","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126021315/form4.xml","form_type":"4"}},{"id":890465,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-20T21:26:14.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":5990,"price":3.338,"value":19994.62,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":1046055,"source":{"system":"sec-edgar","filing":"0001140361-26-006326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126006326/form4.xml","form_type":"4"}},{"id":896252,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:33:30.000Z","date":"2026-02-13","kind":"sale","planned":false,"acquired":false,"shares":12279,"price":3.312,"value":40668.048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":1052045,"source":{"system":"sec-edgar","filing":"0001140361-26-006043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126006043/form4.xml","form_type":"4"}},{"id":904917,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T21:05:30.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":870648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 870,648 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":870648,"derivative":{"exercise_price":3.24,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":870648},"source":{"system":"sec-edgar","filing":"0001140361-26-005412","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126005412/form4.xml","form_type":"4"}},{"id":904916,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-13T21:05:30.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":286028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":1064324,"source":{"system":"sec-edgar","filing":"0001140361-26-005412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126005412/form4.xml","form_type":"4"}},{"id":992427,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-20T21:05:36.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":6276,"price":2.983,"value":18721.308,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":778296,"source":{"system":"sec-edgar","filing":"0001140361-25-042855","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125042855/form4.xml","form_type":"4"}},{"id":1060115,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-08-20T21:00:17.000Z","date":"2025-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2234,"price":3.05,"value":6813.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were withheld by the Company in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":784572,"source":{"system":"sec-edgar","filing":"0001140361-25-032089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125032089/form4.xml","form_type":"4"}},{"id":1136875,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-22T20:05:41.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":2253,"price":6.446,"value":14522.838,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":786806,"source":{"system":"sec-edgar","filing":"0001140361-25-020160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125020160/form4.xml","form_type":"4"}},{"id":1140282,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-20T20:05:40.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":3621,"price":6.528,"value":23637.888,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":789059,"source":{"system":"sec-edgar","filing":"0001140361-25-019899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125019899/form4.xml","form_type":"4"}},{"id":1172443,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-04-14T22:57:31.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":5.08,"value":101600.0,"ownership":{"direct":true},"balance_after":792680,"source":{"system":"sec-edgar","filing":"0001140361-25-013804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125013804/form4.xml","form_type":"4"}},{"id":1245696,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-25T21:01:53.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":16303,"price":10.58,"value":172485.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":772680,"source":{"system":"sec-edgar","filing":"0001140361-25-005844","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125005844/form4.xml","form_type":"4"}},{"id":1269449,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T21:01:35.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":243345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 243,345 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":243345,"derivative":{"exercise_price":9.88,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":243345},"source":{"system":"sec-edgar","filing":"0001140361-25-004296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125004296/form4.xml","form_type":"4"}},{"id":1269448,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-13T21:01:35.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":81655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":788983,"source":{"system":"sec-edgar","filing":"0001140361-25-004296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125004296/form4.xml","form_type":"4"}},{"id":1352533,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-11-25T21:05:16.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":11091,"price":13.054,"value":144781.914,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":707328,"source":{"system":"sec-edgar","filing":"0001140361-24-047755","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124047755/form4.xml","form_type":"4"}},{"id":1427478,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-08-20T20:26:39.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":9650,"price":18.504,"value":178563.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":718419,"source":{"system":"sec-edgar","filing":"0001140361-24-037932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124037932/form4.xml","form_type":"4"}},{"id":1508819,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:33:07.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":false,"shares":67785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16947},"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508818,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:33:07.000Z","date":"2022-02-14","kind":"other","planned":false,"acquired":false,"shares":23940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28763},"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508817,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:33:07.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":9683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":67785,"derivative":{"underlying":"Common Stock","underlying_shares":9683},"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508816,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:33:07.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":23940,"derivative":{"underlying":"Common Stock","underlying_shares":7979},"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508815,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-20T20:33:07.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":9790,"price":23.35,"value":228596.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":728069,"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508814,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-20T20:33:07.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":true,"shares":67785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"security","element":"securityTitle","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":737859,"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508813,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-20T20:33:07.000Z","date":"2022-02-14","kind":"other","planned":false,"acquired":true,"shares":23940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"security","element":"securityTitle","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":670074,"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508812,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-20T20:33:07.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":9683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":646134,"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1508811,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-20T20:33:07.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":636451,"source":{"system":"sec-edgar","filing":"0001140361-24-026878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026878/form4.xml","form_type":"4"}},{"id":1628578,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T01:54:10.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":196336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option represents a right to purchase a total of 196,336 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":196336,"derivative":{"exercise_price":30.01,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":196336},"source":{"system":"sec-edgar","filing":"0001140361-24-008886","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008886/form4.xml","form_type":"4"}},{"id":1628577,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:10.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":66577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"security","element":"securityTitle","label":"F4","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":621339,"source":{"system":"sec-edgar","filing":"0001140361-24-008886","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008886/form4.xml","form_type":"4"}},{"id":1628576,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:10.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":20272,"price":29.838,"value":604875.936,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."}],"balance_after":554762,"source":{"system":"sec-edgar","filing":"0001140361-24-008886","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008886/form4.xml","form_type":"4"}},{"id":1637980,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:05:51.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":38849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":77468,"derivative":{"underlying":"Common Stock","underlying_shares":38849},"source":{"system":"sec-edgar","filing":"0001140361-24-008359","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008359/form4.xml","form_type":"4"}},{"id":1637979,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:05:51.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":31919,"derivative":{"underlying":"Common Stock","underlying_shares":7979},"source":{"system":"sec-edgar","filing":"0001140361-24-008359","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008359/form4.xml","form_type":"4"}},{"id":1637978,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-02-16T21:05:51.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":46828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":575034,"source":{"system":"sec-edgar","filing":"0001140361-24-008359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008359/form4.xml","form_type":"4"}},{"id":1738886,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-11-17T00:09:07.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":39898,"derivative":{"underlying":"Common Stock","underlying_shares":7979},"source":{"system":"sec-edgar","filing":"0001140361-23-053709","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123053709/form4.xml","form_type":"4"}},{"id":1738885,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-11-17T00:09:07.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":532833,"source":{"system":"sec-edgar","filing":"0001140361-23-053709","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123053709/form4.xml","form_type":"4"}},{"id":1800617,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-08-21T20:05:39.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":4767,"price":15.471,"value":73750.257,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."}],"balance_after":524854,"source":{"system":"sec-edgar","filing":"0001140361-23-040694","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123040694/form4.xml","form_type":"4"}},{"id":1807209,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-15T20:06:51.000Z","date":"2023-08-14","kind":"exercise","planned":false,"acquired":false,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":47877,"derivative":{"underlying":"Common Stock","underlying_shares":7979},"source":{"system":"sec-edgar","filing":"0001140361-23-039901","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123039901/form4.xml","form_type":"4"}},{"id":1807208,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-08-15T20:06:51.000Z","date":"2023-08-14","kind":"exercise","planned":false,"acquired":true,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":529621,"source":{"system":"sec-edgar","filing":"0001140361-23-039901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123039901/form4.xml","form_type":"4"}},{"id":1855452,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T23:01:25.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting."}],"balance_after":20500,"derivative":{"exercise_price":2.54,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-23-037190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725922/000120919123037190/doc4.xml","form_type":"4"}},{"id":1884345,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-19T20:05:38.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":4122,"price":21.375,"value":88107.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."}],"balance_after":521642,"source":{"system":"sec-edgar","filing":"0001140361-23-025742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123025742/form4.xml","form_type":"4"}},{"id":1891299,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-05-17T00:04:37.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":false,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":55856,"derivative":{"underlying":"Common Stock","underlying_shares":7979},"source":{"system":"sec-edgar","filing":"0001140361-23-025133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123025133/form4.xml","form_type":"4"}},{"id":1891298,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-17T00:04:37.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":true,"shares":7979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":525764,"source":{"system":"sec-edgar","filing":"0001140361-23-025133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123025133/form4.xml","form_type":"4"}},{"id":1999248,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-02-23T00:27:54.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":12194,"price":19.06,"value":232417.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":536885,"source":{"system":"sec-edgar","filing":"0001140361-23-008102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008102/form4.xml","form_type":"4"}},{"id":1999243,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-02-23T00:25:39.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":31440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":63835,"derivative":{"underlying":"Common Stock","underlying_shares":31440},"source":{"system":"sec-edgar","filing":"0001140361-23-008098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008098/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999242,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-02-23T00:25:39.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":116317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":116317,"derivative":{"underlying":"Common Stock","underlying_shares":116317},"source":{"system":"sec-edgar","filing":"0001140361-23-008098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008098/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999241,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-23T00:25:39.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":348590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 348,590 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":348590,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":348590},"source":{"system":"sec-edgar","filing":"0001140361-23-008098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008098/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999240,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-02-23T00:25:39.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":31440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit award."}],"balance_after":549079,"source":{"system":"sec-edgar","filing":"0001140361-23-008098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008098/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":2010746,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-02-16T21:45:26.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":116317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":116317,"derivative":{"underlying":"Common Stock","underlying_shares":116317},"source":{"system":"sec-edgar","filing":"0001140361-23-007482","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123007482/form4.xml","form_type":"4"}},{"id":2010745,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-16T21:45:26.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":348590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 348,590 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":348590,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":348590},"source":{"system":"sec-edgar","filing":"0001140361-23-007482","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123007482/form4.xml","form_type":"4"}},{"id":2233597,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T22:16:41.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":14501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting."}],"balance_after":14501,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":14501},"source":{"system":"sec-edgar","filing":"0000899243-22-022252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725922/000089924322022252/doc4.xml","form_type":"4"}},{"id":2391523,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2022-02-17T02:02:29.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":95275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":95275,"derivative":{"underlying":"Common Stock","underlying_shares":95275},"source":{"system":"sec-edgar","filing":"0001140361-22-005823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122005823/form4.xml","form_type":"4"}},{"id":2391522,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T02:02:29.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":297037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 297,037 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":297037,"derivative":{"exercise_price":20,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":297037},"source":{"system":"sec-edgar","filing":"0001140361-22-005823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122005823/form4.xml","form_type":"4"}},{"id":2408060,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-02-08T21:43:03.000Z","date":"2022-02-07","kind":"purchase","acquired":true,"shares":22000,"price":17.3415,"value":381513.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.03 to $17.50, inclusive. The reporting person undertakes to provide to Rocket Pharmaceuticals, Inc. (\"RCKT\"), any security holder of RCKT, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":517639,"source":{"system":"sec-edgar","filing":"0001140361-22-004209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122004209/form4.xml","form_type":"4"}},{"id":2763689,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:09:30.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":7475,"price":47.2111,"value":352902.9725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $46.88 to $47.76. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":495639,"source":{"system":"sec-edgar","filing":"0001140361-21-011313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011313/form4.xml","form_type":"4"}},{"id":2763688,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:09:30.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":8872,"price":46.4467,"value":412075.1224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $45.88 to $46.87. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":503114,"source":{"system":"sec-edgar","filing":"0001140361-21-011313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011313/form4.xml","form_type":"4"}},{"id":2763687,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:09:30.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":5919,"price":45.2063,"value":267576.0897,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $44.83 to $45.79. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":511986,"source":{"system":"sec-edgar","filing":"0001140361-21-011313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011313/form4.xml","form_type":"4"}},{"id":2763686,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:09:30.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":7493,"price":45.9409,"value":344235.1637,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $45.67 to $46.57. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":517905,"source":{"system":"sec-edgar","filing":"0001140361-21-011313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011313/form4.xml","form_type":"4"}},{"id":2763698,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":75880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.69,"expiration_date":"2027-04-12","underlying":"Common Stock","underlying_shares":75880},"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763697,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":23003,"price":45.0618,"value":1036556.5854,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $44.67 to $45.66. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":525398,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763696,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":61350,"price":44.2432,"value":2714320.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $43.67 to $44.66. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":548401,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763695,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":3000,"price":45.59,"value":136770.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price and the tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. These shares were relinquished by the Reporting Person and cancelled by the Issuer to cover the exercise price of the options and the tax liability"}],"balance_after":609751,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763694,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":75880,"price":1.69,"value":128237.2,"ownership":{"direct":true},"balance_after":612751,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763693,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-30","kind":"tax_withholding","acquired":false,"shares":8505,"price":44.3392,"value":377104.896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $44.24 to $44.56. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":536871,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763692,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-30","kind":"tax_withholding","acquired":false,"shares":48732,"price":43.8552,"value":2137151.6064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $43.24 to $44.23. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":545376,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763691,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-30","kind":"tax_withholding","acquired":false,"shares":8667,"price":42.7952,"value":370905.9984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $42.245 to $43.23. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":594108,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2763690,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-02T01:08:38.000Z","date":"2021-03-30","kind":"tax_withholding","acquired":false,"shares":19984,"price":41.7999,"value":835329.2016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan entered into in April 2020 under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.  The shares reported herein represent less than 10% of the Reporting Person's holdings"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $41.165 to $42.15. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":614092,"source":{"system":"sec-edgar","filing":"0001140361-21-011312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121011312/form4.xml","form_type":"4"}},{"id":2858711,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-17T02:55:36.000Z","date":"2020-12-31","kind":"gift","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Gaurav D. Shah Irrevocable Trust"},"balance_after":198341,"source":{"system":"sec-edgar","filing":"0001140361-21-005127","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005127/form5.xml","form_type":"5"}},{"id":2858710,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-17T02:55:36.000Z","date":"2020-12-31","kind":"gift","acquired":false,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a Gift of (i) 126,341 shares on December 18, 2020 and (ii) 72,000 shares on December 31, 2020 to the Gaurav D. Shah Irrevocable Trust."}],"balance_after":622759,"source":{"system":"sec-edgar","filing":"0001140361-21-005127","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005127/form5.xml","form_type":"5"}},{"id":2858709,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-17T02:55:36.000Z","date":"2020-12-18","kind":"gift","acquired":true,"shares":126341,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Gaurav D. Shah Irrevocable Trust"},"balance_after":126341,"source":{"system":"sec-edgar","filing":"0001140361-21-005127","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005127/form5.xml","form_type":"5"}},{"id":2858708,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-17T02:55:36.000Z","date":"2020-12-18","kind":"gift","acquired":false,"shares":126341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a Gift of (i) 126,341 shares on December 18, 2020 and (ii) 72,000 shares on December 31, 2020 to the Gaurav D. Shah Irrevocable Trust."}],"balance_after":694759,"source":{"system":"sec-edgar","filing":"0001140361-21-005127","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005127/form5.xml","form_type":"5"}},{"id":2858707,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-17T02:55:36.000Z","date":"2020-12-09","kind":"gift","acquired":true,"shares":207897,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a Gift of 207,897 shares on December 9, 2020 to Falguni G. Shah, the spouse of the Reporting Person."}],"balance_after":207897,"source":{"system":"sec-edgar","filing":"0001140361-21-005127","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005127/form5.xml","form_type":"5"}},{"id":2858706,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-17T02:55:36.000Z","date":"2020-12-09","kind":"gift","acquired":false,"shares":207897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a Gift of 207,897 shares on December 9, 2020 to Falguni G. Shah, the spouse of the Reporting Person."}],"balance_after":821100,"source":{"system":"sec-edgar","filing":"0001140361-21-005127","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121005127/form5.xml","form_type":"5"}},{"id":2874304,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-09T01:41:24.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 185,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":185000,"derivative":{"exercise_price":62.32,"expiration_date":"2031-02-03","underlying":"Common Sock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001140361-21-003782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121003782/form4.xml","form_type":"4"}},{"id":3194278,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-26T23:48:29.000Z","date":"2020-03-24","kind":"exercise","acquired":false,"shares":90925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and reported on this Form 4 were required to be exercised or otherwise forfeited in 2020 due to their upcoming expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and immediately exercisable and will expire under its own terms this year."}],"balance_after":0,"derivative":{"exercise_price":0.44,"expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":90925},"source":{"system":"sec-edgar","filing":"0001140361-20-007081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120007081/form4.xml","form_type":"4"}},{"id":3194277,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-03-26T23:48:29.000Z","date":"2020-03-24","kind":"tax_withholding","acquired":false,"shares":32645,"price":13.78,"value":449848.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price and the tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of on this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer to cover the exercise price of the options and the tax liability,"}],"balance_after":1028997,"source":{"system":"sec-edgar","filing":"0001140361-20-007081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120007081/form4.xml","form_type":"4"}},{"id":3194276,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-03-26T23:48:29.000Z","date":"2020-03-24","kind":"exercise","acquired":true,"shares":90925,"price":0.43,"value":39097.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and reported on this Form 4 were required to be exercised or otherwise forfeited in 2020 due to their upcoming expiration."}],"balance_after":1061642,"source":{"system":"sec-edgar","filing":"0001140361-20-007081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120007081/form4.xml","form_type":"4"}},{"id":3243583,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-27T22:36:27.000Z","date":"2020-02-25","kind":"exercise","acquired":false,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and reported on this Form 4 were required to be exercised or otherwise forfeited in 2020 due to their upcoming expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and immediately exercisable and will expire under its own terms this year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"As the result of an administrative error, the Form 3 previously filed with the Securities and Exchange Commission on January 16, 2018 incorrectly reported the expiration date of this option. The expiration date is corrected on this Form 4."}],"balance_after":90925,"derivative":{"exercise_price":0.44,"expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001209191-20-013480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000120919120013480/doc4.xml","form_type":"4"}},{"id":3243582,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-02-27T22:36:27.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":6233,"price":20.15,"value":125594.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of on this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer to cover the exercise price of the options."}],"balance_after":970717,"source":{"system":"sec-edgar","filing":"0001209191-20-013480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000120919120013480/doc4.xml","form_type":"4"}},{"id":3243581,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-02-27T22:36:27.000Z","date":"2020-02-25","kind":"exercise","acquired":true,"shares":290000,"price":0.4332,"value":125628.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and reported on this Form 4 were required to be exercised or otherwise forfeited in 2020 due to their upcoming expiration."}],"balance_after":976950,"source":{"system":"sec-edgar","filing":"0001209191-20-013480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000120919120013480/doc4.xml","form_type":"4"}},{"id":3281875,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T22:08:18.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":383306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 383,306 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 6, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":383306,"derivative":{"exercise_price":22.72,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":383306},"source":{"system":"sec-edgar","filing":"0001209191-20-008018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000120919120008018/doc4.xml","form_type":"4"}},{"id":3611515,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-06T00:23:32.000Z","date":"2019-03-05","kind":"sale","acquired":false,"shares":25000,"price":16.9,"value":422500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $16.43 to $17.73. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":686950,"source":{"system":"sec-edgar","filing":"0001140361-19-004456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119004456/form4.xml","form_type":"4"}},{"id":3611514,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-06T00:23:32.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":24900,"price":17.28,"value":430272.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $16.76 to $17.71. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":711950,"source":{"system":"sec-edgar","filing":"0001140361-19-004456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119004456/form4.xml","form_type":"4"}},{"id":3611513,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-06T00:23:32.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":25000,"price":17.34,"value":433500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $17.01 to $17.56. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":736850,"source":{"system":"sec-edgar","filing":"0001140361-19-004456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119004456/form4.xml","form_type":"4"}},{"id":3682488,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T23:29:45.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":315700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 315,700 shares of the Issuer's Common Stock, 105,236 of which will become fully vested and exercisable on January 28, 2020, with the remaining 210,464 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":315700,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":315700},"source":{"system":"sec-edgar","filing":"0001140361-19-002001","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119002001/form4.xml","form_type":"4"}},{"id":3976180,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21205,"kind":"person","name":"Shah Gaurav","position":1,"cik":"0001725922","reported_name":"Shah Gaurav","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-03T00:12:22.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":395000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 395,000 shares of the Issuer's Common Stock, 131,672 of which will become fully vested and exercisable on March 29, 2019, with the remaining 263,328 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":395000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":395000},"source":{"system":"sec-edgar","filing":"0000899243-18-009118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924318009118/doc4.xml","form_type":"4"}}]}